SCHEMBL1628849

SCHEMBL1628849

COc1cc(OC)c(S(=O)(=O)N(C)C2CCCCC2)cc1-c1ccnn1-c1ccccc1Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
MCOLN3 Q8TDD5 2/20 0.45
HTT P42858 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
BRD4 O60885 2/20 0.42
BRD3 Q15059 2/20 0.42
BRD2 P25440 1/20 0.42
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
ALDH1A1 P00352 4/20 0.37
KDM4E B2RXH2 1/20 0.37
PKM P14618 1/20 0.36
TP53 P04637 2/20 0.36
GAA P10253 2/20 0.36
MAPT P10636 1/20 0.35
TSHR P16473 1/20 0.35
LMNA P02545 3/20 0.34
KCNN4 O15554 1/20 0.34
HSP90AA1 P07900 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1631566 0.86 TSHR (0.44) ALDH1A1TP53MAPTTSHRLMNA
SCHEMBL1628860 0.85 HSP90AA1 (0.45) MEN1KMT2AMCOLN3HTTL3MBTL1
SCHEMBL1629889 0.84 HSP90AA1 (0.43) ALDH1A1TP53MAPTTSHRLMNA
SCHEMBL1630004 0.83 HSP90AA1 (0.38) ALDH1A1MAPTTSHRKCNN4HSP90AA1
SCHEMBL1628804 0.82 TSHR (0.52) KMT2AMCOLN3ALDH1A1KDM4ETP53
SCHEMBL1630236 0.82 ALDH1A1 (0.41) MEN1KMT2AMCOLN3ALDH1A1KDM4E
SCHEMBL1216917 0.81 MAPT (0.44) MEN1KMT2AHTTL3MBTL1HTR2C
SCHEMBL1631603 0.81 HSP90AA1 (0.37) MEN1KMT2AL3MBTL1ALDH1A1MAPT
SCHEMBL1219165 0.81 HSP90AA1 (0.40) ALDH1A1TP53GAAMAPTTSHR
SCHEMBL1629173 0.80 HSP90AA1 (0.38) HTTALDH1A1KDM4ETSHRKCNN4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P MEN1 4538/4885KMT2A 4362/4885MCOLN3 4182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.